← All trials
NCT03422731
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 15, 2018
- Primary completion
- Nov 6, 2024
- Completion date
- Nov 6, 2024
- First posted
- Feb 6, 2018
- Last posted
- Nov 15, 2022
- Enrollment
- 74
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- City of Hope National Medical CenterLead sponsor
- National Cancer Institute (NCI)Collaborator
- City of Hope National Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.